首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
hepatic myelopathy相关文献:
Hepatic myelopathy.
Bourgeois S.
Neurology. 1993 Mar;43(3 Pt 1):629. doi: 10.1212/wnl.43.3_part_1.629.
PMID:8507254
[Hepatic myelopathy, hepatic neuropathy].
Tsukaguchi M, Takeuchi H.
Ryoikibetsu Shokogun Shirizu. 2000;(29 Pt 4):133-5.
PMID:11031914
Liver Transplantation Reverses Hepatic Myelopathy in Hepatitis B-Related Decompensated Liver Cirrhosis: Case Report and Review of the Literature.
Zhu Z, Liu Y, Wu W, Huang D, Guo Y, Zheng H, Wang N, Xu Z, Li X, Qin J, Liu L, Nashan B.
Transplant Proc. 2022 Jan-Feb;54(1):158-160. doi: 10.1016/j.transproceed.2021.11.016. Epub 2021 Dec 24.
PMID:34961599
Hepatic myelopathy improved by embolization of spontaneous portosystemic shunt and partial splenic artery embolization - Literature review.
Liu F, Deng J, Li Z, Huang Z.
Rev Esp Enferm Dig. 2026 Feb;118(2):119-120. doi: 10.17235/reed.2025.11451/2025.
PMID:41020951
Hepatic myelopathy neurological complication of chronic liver disease: two case reports.
Mhiri M, Ben Abdelwahed M, Dhiflaoui MA, Ben Dhia R, Gouta N, Jemni I, Baklouti R, Zakhama M, Gueddiche A, Loghmari MH, Ben Chaabene N, Safer L, Frih-Ayed M.
J Med Case Rep. 2024 Jun 17;18(1):281. doi: 10.1186/s13256-024-04495-2.
PMID:38880918
Hepatic myelopathy with spastic paraparesis.
Utku U, Asil T, Balci K, Uzunca I, Celik Y.
Clin Neurol Neurosurg. 2005 Oct;107(6):514-6. doi: 10.1016/j.clineuro.2004.10.002. Epub 2004 Nov 10.
PMID:16202825
Metabolic and Toxic Myelopathies.
Slama MCC, Berkowitz AL.
Semin Neurol. 2021 Jun;41(3):309-326. doi: 10.1055/s-0041-1725150. Epub 2021 May 19.
PMID:34010972
Partial Reversal of Shunt Myelopathy and Hepatic Parkinsonism Using Balloon-Occluded Retrograde Transvenous Obliteration.
Mukund A, Premkumar M, Srivastava A, Baby A, Patidar Y, Sarin S.
Cardiovasc Intervent Radiol. 2024 Jun;47(6):847-851. doi: 10.1007/s00270-024-03729-6. Epub 2024 Apr 22.
PMID:38649445
Metabolic and Toxic Myelopathies.
Parks NE.
Continuum (Minneap Minn). 2021 Feb 1;27(1):143-162. doi: 10.1212/CON.0000000000000963.
PMID:33522740
Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature.
Caldwell C, Werdiger N, Jakab S, Schilsky M, Arvelakis A, Kulkarni S, Emre S.
Liver Transpl. 2010 Jul;16(7):818-26. doi: 10.1002/lt.22077.
PMID:20583082
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3